L 377202
Alternative Names: Doxorubicin peptide conjugate - MerckLatest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Merck & Co
- Class Anthracyclines; Cytostatic antibiotics
- Mechanism of Action Reactive oxygen species stimulants; RNA synthesis inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Prostate cancer